ArticleOPEN ACCESS

Nirmatrelvir combined with ritonavir for preventing and treating COVID-19

Cochrane Database of Systematic Reviews
DOI: 10.1002/14651858.CD015395
46Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the efficacy and safety of nirmatrelvir/ritonavir (Paxlovid®) plus standard of care compared to standard of care with or without placebo, or any other proven intervention for treating COVID-19 and for preventing SARS-CoV-2 infection.

Cite

CITATION STYLE

APA

Reis, S., Popp, M., Kuehn, R., Metzendorf, M. I., Gagyor, I., Kranke, P., … Weibel, S. (2022, April 11). Nirmatrelvir combined with ritonavir for preventing and treating COVID-19. Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd. https://doi.org/10.1002/14651858.CD015395

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free